 Connection
Kimberly Simmons to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Kimberly Simmons has written about Antibodies, Monoclonal, Humanized.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.389 |
|
|
|
-
O'Donnell HK, Simmons KM, Gitelman SE, Dex T, Hill R, Wieloch M, Zaccai J, D'Souza J, Ginchereau Sowell F, Turnbull J, Hood KK. Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type?1 diabetes. Diabetes Obes Metab. 2025 May; 27(5):2495-2506.
Score: 0.162
-
Ramos EL, Dayan CM, Chatenoud L, Sumnik Z, Simmons KM, Szypowska A, Gitelman SE, Knecht LA, Niemoeller E, Tian W, Herold KC. Teplizumab and ?-Cell Function in Newly Diagnosed Type 1 Diabetes. N Engl J Med. 2023 Dec 07; 389(23):2151-2161.
Score: 0.148
-
Simmons K, Michels AW. Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease. Rheum Dis Clin North Am. 2014 Nov; 40(4):797-811.
Score: 0.079
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|